INOVIO Pharmaceuticals shares surged more than threefold in pre-market trading after the US Food and Drug Administration approved a drug to treat rare respiratory conditions.

INOVIO Pharmaceuticals shares surged more than threefold in pre-market trading after the US Food and Drug Administration approved a drug to treat rare respiratory conditions.